Abstract:Two important features are required for promising radiosensitizers: one is selective tumor cell targeting to enhance the therapeutic outcome via lethal DNA damage and the other is rapid clearance to enable excellent biocompatibility for potential clinical application. Herein, ultrasmall gold nanoparticles (Au NPs) with diameter smaller than 5 nm were prepared and covered with a multifunctional peptide to endow them with selective tumor cell uptake capability. Combined with X-ray irradiation, the responsive Au NPs demonstrated superior radio-sensitizing toxicity and rapid renal clearance in vivo. Methods: A responsive peptide (Tat-R-EK) consists of three build blocks were used: a cell and even nuclear penetrating block derived from human immunodeficiency virus-1 transactivator of transcription protein (Tat), an cathepsin B cleavable linker, and a zwitterionic antifouling block. Ultrasmall Au NPs were prepared and then covered by the peptide via the Au-S bonds between gold and thiol groups from cysteine. The morphology, colloidal stability and the responsiveness of obtained Au@Tat-R-EK NPs were studied using transmittance electron microscopy and dynamic laser scattering. The selective cancer cell uptake and accumulation of Au@Tat-R-EK NPs in cancer tissue were studied via ICP-MS in vitro and in vivo, respectively. The cytotoxicity of Au@Tat-R-EK NPs on HepG2 cancer cells was evaluated in terms of cell viability, DNA damage, intracellular reactive oxygen species generation, and apoptosis analysis. Finally, the biocompatibility and tumor destruction ability against orthotopic LM3 liver cancers were verified in vivo. Results: Multifunctional peptide modified ultrasmall Au NPs were successfully prepared. The Au NPs exhibited enough colloidal stability and cathepsin B-responsive surface change, leading to selectively uptake by cancer cells in vitro and accumulation to tumor sites in vivo. Combined with X-ray irradiation, the responsive Au NPs demonstrated superior radio-sensitizing cytotoxicity in vitro and therapeutic outcome on mouse liver cancer in vivo. The ultrasmall size enables rapid clearance of the Au NPs, guarantees the biocompatibility in vivo for potential clinical applications. Conclusion: Some obstacles faced by the Au NPs-based radiotherapy, such as short circulation half-life, non-specific distribution, slow clearance and low radio-sensitizing effect, were effective solved through rational design of the smart nanomedicine. This work provides new insight in designing tumor microenvironment-responsive nanomedicine in cancer radiotherapy.

Inhibition of the Thioredoxin System for Radiosensitization Therapy of Cancer

Cancer Radiosensitizers.

Novel Strategies for Tumor Radiosensitization Mediated by Multifunctional Gold-Based Nanomaterials

Emerging Bismuth Chalcogenides Based Nanodrugs for Cancer Radiotherapy

Targeted Delivery of Nano-Radiosensitizers for Tumor Radiotherapy

Tumor microenvironment-responsive multifunctional peptide coated ultrasmall gold nanoparticles and their application in cancer radiotherapy.

Emerging Nanoradiosensitizers and Nanoradioprotectants for Enhanced Cancer Theranostics

Enhancement of Radiosensitization by Metal-Based Nanoparticles in Cancer Radiation Therapy

Organelle-localized radiosensitizers

Stimuli‐Responsive Nanoradiosensitizers for Enhanced Cancer Radiotherapy

Emerging Strategies of Nanomaterial‐Mediated Tumor Radiosensitization

Catalytic Radiosensitization: Insights from Materials Physicochemistry

Molecular pathways associated with oxidative stress and their potential applications in radiotherapy (Review)

Synthetic nanoparticles for delivery of radioisotopes and radiosensitizers in cancer therapy

Targeting the Thioredoxin System for Cancer Therapy.

Selenadiazole Derivatives As Potent Thioredoxin Reductase Inhibitors That Enhance the Radiosensitivity of Cancer Cells

Multifunctional High-Z Nanoradiosensitizers for Multimodal Synergistic Cancer Therapy.

Empowering Radiotherapy: Harnessing Nanomedicines to Enhance Radiation Response and Boost Antitumor Efficacy

Radiosensitizers: Enhanced Tumor Accumulation of Sub‐2 nm Gold Nanoclusters for Cancer Radiation Therapy (Adv. Healthcare Mater. 1/2014)

Tailoring Bi-based Nanoparticles for Enhanced Radiosensitivity in Cancer Therapy

Overcoming Radioresistance in Tumor Therapy by Alleviating Hypoxia and Using the HIF-1 Inhibitor